Plasma Biomarkers of Brain Injury in Neonatal Hypoxic‐Ischemic Encephalopathy

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Jornal de Pediatria

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpeds.2017.10.060PMID 29478510
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Making a (cautious) case for expanding reproductive genetic carrier screens

  2018cited by this paper
• High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial

  2016influential reference
• Circulating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury

  2016cited by this paper
• Effects of PTEN inhibition on the regulation of Tau phosphorylation in rat cortical neuronal injury after oxygen and glucose deprivation

  2016cited by this paper
• SBDPs and Tau proteins for diagnosis and hypothermia therapy in neonatal hypoxic ischemic encephalopathy

  2016cited by this paper
• Association of Brain Injury and Neonatal Cytokine Response during Therapeutic Hypothermia (TH) in Newborns with Hypoxic-Ischemic Encephalopathy (HIE)

  2015cited by this paper
• Multivariate Analysis of Traumatic Brain Injury: Development of an Assessment Score

  2015cited by this paper
• Traumatic brain injury: recent advances in plasticity and regeneration.

  2015cited by this paper
• Biomarkers S100B and Neuron-Specific Enolase Predict Outcome in Hypothermia-Treated Encephalopathic Newborns*

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• UCH-L1 and GFAP Serum Levels in Neonates with Hypoxic–Ischemic Encephalopathy: A Single Center Pilot Study

  2014cited by this paper
• Serum tau protein level serves as a predictive factor for neurological prognosis in neonatal asphyxia.

  2014cited by this paper
• Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy.

  2014cited by this paper
• Serum Biomarkers of MRI Brain Injury in Neonatal Hypoxic Ischemic Encephalopathy Treated With Whole-Body Hypothermia: A Pilot Study

  2013cited by this paper
• Cooling for newborns with hypoxic ischaemic encephalopathy.

  2013cited by this paper
• EEG background patterns and prognostication of neonatal encephalopathy in the era of hypothermia.

  2013cited by this paper
• Cooling for newborns with hypoxic ischaemic encephalopathy.

  2013cited by this paper
• Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples.

  2013cited by this paper
• Erythropoietin as a neuroprotectant for neonatal brain injury: animal models.

  2013cited by this paper
• Impact of therapeutic hypothermia on MRI diffusion changes in neonatal encephalopathy

  2012cited by this paper
• Serum S100B and neuron‐specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia

  2012cited by this paper
• Dynamic Changes of Cerebral-Specific Proteins in Full-Term Newborns with Hypoxic–Ischemic Encephalopathy

  2012cited by this paper
• Biomarkers of brain injury in neonatal encephalopathy treated with hypothermia.

  2012cited by this paper
• Brain injury following trial of hypothermia for neonatal hypoxic–ischaemic encephalopathy

  2012cited by this paper
• Serum cytokines in a clinical trial of hypothermia for neonatal hypoxic-ischemic encephalopathy

  2012cited by this paper
• Cord blood erythropoietin and interleukin-6 for prediction of intraventricular hemorrhage in the preterm neonate

  2011cited by this paper
• Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop.

  2011cited by this paper
• Treatment advances in neonatal neuroprotection and neurointensive care.

  2011cited by this paper
• Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling.

  2011cited by this paper
• Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic–ischaemic encephalopathy: a nested substudy of a randomised controlled trial

  2010cited by this paper
• A Pilot Study of Novel Biomarkers in Neonates With Hypoxic-Ischemic Encephalopathy

  2010cited by this paper
• Activin A in asphyxiated full-term newborns with hypoxic ischemic encephalopathy.

  2010cited by this paper
• Pediatric Basic and Advanced Life Support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations

  2010cited by this paper
• Cord blood brain derived neurotrophic factor: diagnostic and prognostic marker in fullterm newborns with perinatal asphyxia.

  2009cited by this paper
• Biological and methodological features of the measurement of S100B, a putative marker of brain injury.

  2008cited by this paper
• Cytokines and perinatal brain damage.

  2008cited by this paper
• Increased Fetal Plasma and Amniotic Fluid Erythropoietin Concentrations: Markers of Intrauterine Hypoxia

  2008cited by this paper
• High urinary concentrations of activin A in asphyxiated full-term newborns with moderate or severe hypoxic ischemic encephalopathy.

  2007cited by this paper
• Recombinant Erythropoietin Is Neuroprotective in a Novel Mouse Oxidative Injury Model

  2007cited by this paper
• Whole-Body Hypothermia for Neonates With Hypoxic–Ischemic Encephalopathy

  2006cited by this paper
• Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial.

  2005cited by this paper
• Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice

  2005cited by this paper
• Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy.

  2005cited by this paper
• Measuring functional skills in preschool children at risk for neurodevelopmental disabilities.

  2005cited by this paper
• Erythropoietin Protects Dopaminergic Neurons and Improves Neurobehavioral Outcomes in Juvenile Rats after Neonatal Hypoxia-Ischemia

  2005cited by this paper
• Cerebrospinal fluid activin a measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy.

  2004cited by this paper
• S100 Protein in Serum as a Prognostic Marker for Cerebral Injury in Term Newborn Infants with Hypoxic Ischemic Encephalopathy

  2004cited by this paper
• Clinical signs predict 30-month neurodevelopmental outcome after neonatal encephalopathy.

  2004cited by this paper
• Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy.

  2004cited by this paper
• Value of biochemical markers for outcome in term infants with asphyxia.

  2004cited by this paper
• Predictive Value of Brain-Specific Proteins in Serum for Neurodevelopmental Outcome after Birth Asphyxia

  2003cited by this paper
• Functional Assessments of Preschool Children: Optimizing Developmental and Family Supports in Early Intervention.

  2001cited by this paper
• The Biology of Erythropoietin in the Central Nervous System and Its Neurotrophic and Neuroprotective Potential

  2001cited by this paper
• Early Biochemical Indicators of Hypoxic-Ischemic Encephalopathy after Birth Asphyxia

  2001cited by this paper
• Statistical computing

  2000cited by this paper
• BDNF Protects the Neonatal Brain from Hypoxic-Ischemic InjuryIn Vivo via the ERK Pathway

  2000cited by this paper
• Neuronal death and survival in two models of hypoxic-ischemic brain damage.

  1999cited by this paper
• Intra-individual stability of rate of gross motor development in full-term infants.

  1998cited by this paper
• Assessment of gross motor skills of at‐risk infants: predictive validity of the Alberta Infant Motor Scale

  1998cited by this paper
• The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcome

  1997cited by this paper
• Prognostic value of background patterns in the neonatal EEG.

  1993cited by this paper
• Construction and validation of the Alberta Infant Motor Scale (AIMS).

  1992cited by this paper
• The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase.

  1989cited by this paper
• Prediction of perinatal brain damage by cord plasma vasopressin, erythropoietin, and hypoxanthine values.

  1988cited by this paper
• The distribution of tau in the mammalian central nervous system

  1985cited by this paper
• Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study.

  1976cited by this paper

• Plasma brain-related biomarkers and potential therapeutic targets in pediatric ECMO

  2025cites this paper
• BOston Neonatal Brain Injury Data for Hypoxic Ischemic Encephalopathy (BONBID-HIE): I. MRI and Lesion Labeling

  2025cites this paper
• Neurons as Immunomodulators: From Rapid Neural Activity to Prolonged Regulation of Cytokines and Microglia.

  2025cites this paper
• Changes in molecular biomarkers of neurotoxicity in newborns following prenatal exposure to organophosphate compounds.

  2025cites this paper
• Association of blood biomarkers for neural injury with recent, frequent exposure to partnered sexual strangulation in young adult women.

  2025cites this paper
• The role of proteinuria on a simple urinalysis in neonatal hypoxic–ischemic encephalopathy: association with clinical and neurodevelopmental outcomes

  2025cites this paper
• The Value of Netrin-1 and Neuron Specific Enolase biomarkers in neonates with Hypoxic İschemic Encephalopathy

  2025cites this paper
• Analysis of Energy Metabolism and Lipid Spatial Distribution in Hypoxic-Ischemic Encephalopathy Revealed by MALDI-MSI

  2025cites this paper
• Neuroprotective Effect of Salvianolic Acid C in Neonatal Rats Following Hypoxic-ischemic Brain Damage

  2025cites this paper
• Inflammation mediated brain damage and cytokine expression in a maternally derived murine model for preterm hypoxic-ischemic encephalopathy

  2025cites this paper
• Neonatal sevoflurane exposure induces plasma biomarkers of inflammation in infant rhesus macaques

  2025cites this paper
• Intermittent Hypoxemia and Brain Injury Biomarker S100B in Preterm Infants

  2025cites this paper
• Evaluating neuronal damage biomarkers at birth for predicting neurodevelopmental risks in foetal growth restriction

  2024cites this paper
• Blood and CSF levels of brain-derived neurotrophic factor in patients with encephalopathy/encephalitis: a systematic review and meta-analysis

  2024cites this paper
• Pro-inflammatory biomarkers and long term neurological outcomes in hypothermia plus melatonin treated asphyxiated newborns. A preliminary approach

  2024cites this paper
• Inter-alpha Inhibitor Proteins Modulate Microvascular Endothelial Components and Cytokines After Exposure to Hypoxia–Ischemia in Neonatal Rats

  2024cites this paper
• Effect of Early Inhibition of Toll-Like Receptor 4 on Hippocampal Plasticity in a Neonatal Rat Model of Hypoxic-Ischemic Brain Damage

  2024cites this paper
• Blood Lactate Levels during Therapeutic Hypothermia and Neurodevelopmental Outcome or Death at 18–24 Months of Age in Neonates with Moderate and Severe Hypoxic-Ischemic Encephalopathy

  2024cites this paper
• Seizures may worsen outcomes of neonatal hypoxic ischemic encephalopathy: a longitudinal serum biomarkers study

  2024cites this paper
• Exploratory factor analysis yields grouping of brain injury biomarkers significantly associated with outcomes in neonatal and pediatric ECMO

  2024influential citation
• Higher levels of brain injury biomarker tau are associated with unfavorable outcomes in patients supported with ECMO following cardiac arrest

  2024cites this paper
• MicroRNAs as biomarkers of brain injury in neonatal encephalopathy: an observational cohort study

  2024cites this paper
• Plasmatic profiles of cytokines/chemokines, glial fibrillary acidic protein (GFAP) and MRI brain damage in neonates with hypoxic ischemic encephalopathy (HIE).

  2024cites this paper
• Bioactive metabolites of OMEGA-6 and OMEGA-3 fatty acids are associated with inflammatory cytokine concentrations in maternal and infant plasma at the time of delivery.

  2024cites this paper
• Epileptic seizures caused by hypoxic-ischemic damage to the central nervous system

  2024cites this paper
• Analysis of risk factors and hypoxic-ischemic damage consequences to central nervous system in newborns

  2024cites this paper
• Longitudinal perturbations of plasma nuclear magnetic resonance profiles in neonatal encephalopathy

  2023cites this paper
• Serum biomarkers of hypoxic-ischemic brain injury.

  2023cites this paper
• Serum tau protein and myelin basic protein in pediatric patients with congenital heart defects undergoing cardiac surgery: preliminary assessment as novel neuromarkers of brain injury

  2023cites this paper
• Early-stage effect of HIBD on neuro-motor function and organic composition of neurovascular units in neonatal rats

  2023cites this paper
• Atorvastatin Promotes Pro/anti-inflammatory Phenotypic Transformation of Microglia via Wnt/β-catenin Pathway in Hypoxic-Ischemic Neonatal Rats

  2023cites this paper
• Effects of Neonatal Hypoxic-Ischemic Injury on Brain Sterol Synthesis and Metabolism

  2023cites this paper
• Newborns with Favourable Outcomes after Perinatal Asphyxia Have Upregulated Glucose Metabolism-Related Proteins in Plasma

  2023cites this paper
• Effects of Butylphthalide Combined with Fasudil on Inflammatory Factors, Cognitive Function and Vascular Endothelial Function in Patients with Subarachnoid Hemorrhage Complicated with Cerebral Vasospasm

  2023cites this paper
• Preservation of Biomarkers Associated with Alzheimer’s Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia

  2023cites this paper
• Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy

  2023cites this paper
• BOston Neonatal Brain Injury Dataset for Hypoxic Ischemic Encephalopathy (BONBID-HIE): Part I. MRI and Manual Lesion Annotation

  2023cites this paper
• Pathophysiological aspects of neonatal anoxia and temporal expression of S100β in different brain regions

  2023cites this paper
• Abnormal expression and role of MicroRNA‐214‐3p/SLC8A1 in neonatal Hypoxic‐Ischaemic encephalopathy

  2023cites this paper
• Plasma UCHL-1 as a biomarker of brain injury in hospitalized foals with neonatal encephalopathy.

  2023cites this paper
• The Protective Effects of Apple Pectin and Citrus Pectins on Post-Cerebral I/R Depression in Mice: The Role of NF-κB-p65 and pSTAT3 pathways

  2023cites this paper
• Temperature dysregulation during therapeutic hypothermia predicts long-term outcome in neonates with HIE

  2023cites this paper
• TNF‐α interference ameliorates brain damage in neonatal hypoxic–ischemic encephalopathy rats by regulating the expression of NT‐3 and TRKC

  2023cites this paper
• Neuroprotective effects of oxymatrine on hypoxic-ischemic brain damage in neonatal rats by activating the Wnt/β-catenin pathway.

  2023cites this paper
• Brain-derived neutrophic factor, glutamate and markers of apoptosis in the blood of patients with prolonged disorders of consciousness

  2023cites this paper
• Diagnostic and Therapeutic Roles of the “Omics” in Hypoxic–Ischemic Encephalopathy in Neonates

  2022influential citation
• Plasma biomarkers of evolving encephalopathy and brain injury in neonates with hypoxic ischemic encephalopathy (HIE).

  2022cites this paper
• Recent advances in diagnostics of neonatal hypoxic ischemic encephalopathy

  2022cites this paper
• Concentration of Serum Biomarkers of Brain Injury in Neonates With a Low Cord pH With or Without Mild Hypoxic-Ischemic Encephalopathy

  2022cites this paper
• Neuroprotective therapies in the NICU in term infants: present and future

  2022cites this paper
• THE IMPACT OF BLAST-INDUSED TRAUMATIC BRAIN INJURY ON PASSIVE AVOIDANCE RESPONSE

  2022cites this paper
• Could Nucleated Red Blood Cell Count Be Useful in the Diagnosis of Moderate to Severe Hypoxic-ischemic Encephalopathy?

  2022cites this paper
• Heliox Preconditioning Exerts Neuroprotective Effects on Neonatal Ischemia/Hypoxia Injury by Inhibiting Necroptosis Induced by Ca^2+ Elevation

  2022cites this paper
• The NESHIE and CP Genetics Resource (NCGR): A database of genes and variants reported in neonatal encephalopathy with suspected hypoxic ischemic encephalopathy (NESHIE) and consequential cerebral palsy (CP)

  2022cites this paper
• Predictive Value of Heat-Shock Protein Gene Expression on Severe Neonatal Hypoxic-Ischemic Encephalopathy

  2022cites this paper
• Combined GFAP, NFL, Tau, and UCH-L1 panel increases prediction of outcomes in neonatal encephalopathy

  2022cites this paper
• Prognostic Neurobiomarkers in Neonatal Encephalopathy

  2022cites this paper
• Long Non-coding RNA Peg13 Alleviates Hypoxic-Ischemic Brain Damage in Neonatal Mice via miR-20a-5p/XIAP Axis

  2022cites this paper
• Research advances in the role of endogenous neurogenesis on neonatal hypoxic-ischemic brain damage

  2022cites this paper
• Early nutritional intake influences the serum levels of nerve growth factor (NGF) and brain-derived neurotrophic factor in preterm newborns

  2022cites this paper
• Association of Routinely Measured Proinflammatory Biomarkers With Abnormal MRI Findings in Asphyxiated Neonates Undergoing Therapeutic Hypothermia

  2021cites this paper
• Effect of Hypothermia on Serum Myelin Basic Protein and Tumor Necrosis Factor-α in Neonatal Hypoxic-Ischemic Encephalopathy

  2021cites this paper
• Putting Cells in Motion: Advantages of Endogenous Boosting of BDNF Production

  2021cites this paper
• Cytokine and chemokine responses to injury and treatment in a nonhuman primate model of hypoxic-ischemic encephalopathy treated with hypothermia and erythropoietin

  2021cites this paper
• Serial Plasma Biomarkers of Brain Injury in Infants with Neonatal Encephalopathy treated with Therapeutic Hypothermia

  2021cites this paper
• Elevated serum IL-10 is associated with severity of neonatal encephalopathy and adverse early childhood outcomes

  2021cites this paper
• Whole-exome sequencing with targeted analysis and epilepsy after acute symptomatic neonatal seizures

  2021cites this paper
• Identifying Early Diagnostic Biomarkers Associated with Neonatal Hypoxic-Ischemic Encephalopathy

  2021cites this paper
• Perinatal Blood Biomarkers for the Identification of Brain Injury in Very Low Birth Weight Growth Restricted Infants

  2021cites this paper
• Bedside and laboratory neuromonitoring in neonatal encephalopathy.

  2021cites this paper
• Effect of erythropoietin administration on the expression of brain-derived neurotrophic factor, stromal cell-derived Factor-1, and neuron-specific enolase in traumatic brain injury: A literature review

  2021cites this paper
• Temporal brain microRNA expression changes in a mouse model of neonatal hypoxic–ischemic injury

  2021cites this paper
• Оптимизация диагностики гипоксического поражения головного мозга у доношенных новорождённых

  2021cites this paper
• Comprehensive Analysis of RNA Expression Profile Identifies Hub miRNA-circRNA Interaction Networks in the Hypoxic Ischemic Encephalopathy

  2021cites this paper
• Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial

  2021cites this paper
• Altered Cytokine Endotoxin Responses in Neonatal Encephalopathy Predict MRI Outcomes

  2021cites this paper
• Enhanced S100B expression in T and B lymphocytes in spontaneous preterm birth and preeclampsia

  2021cites this paper
• Therapeutic Hypothermia Modulates the Relationships Between Indicators of Severity of Neonatal Hypoxic Ischemic Encephalopathy and Serum Biomarkers

  2021influential citation
• Optimization of Hypoxic Brain Injuries Diagnostics in Full-Term Newborns

  2021influential citation
• Chlorogenic acid exerts neuroprotective effect against hypoxia-ischemia brain injury in neonatal rats by activating Sirt1 to regulate the Nrf2-NF-κB signaling pathway

  2021cites this paper
• Lactate Predicts Neurological Outcomes after Perinatal Asphyxia in Post-Hypothermia Era: A Prospective Cohort Study

  2021cites this paper
• MiR-582-5p attenuates neonatal hypoxic-ischemic encephalopathy by targeting high mobility group box 1 (HMGB1) through inhibiting neuroinflammation and oxidative stress.

  2021cites this paper
• Persephin as a diagnostic marker of acute brain injury in critically ill newborns: a clinical trial

  2021cites this paper
• Can Erythropoietin Reduce Hypoxemic Neurological Damages in Neonates With Congenital Heart Defects?

  2021cites this paper
• Serum brain injury biomarkers are gestationally and post-natally regulated in non-brain injured neonates

  2021cites this paper
• F-box and WD repeat domain-containing 7 (FBXW7) mediates the hypoxia inducible factor-1α (HIF-1α)/vascular endothelial growth factor (VEGF) signaling pathway to affect hypoxic-ischemic brain damage in neonatal rats

  2021cites this paper
• Efficacy of different treatment times of mild cerebral hypothermia on oxidative factors and neuroprotective effects in neonatal patients with moderate/severe hypoxic–ischemic encephalopathy

  2020cites this paper
• Frequency of Cytokine Gene Polymorphism in Full-Term Newborns with Hypoxic Events

  2020cites this paper
• DTI parameters in neonates with hypoxic-ischemic encephalopathy after total body hypothermia

  2020cites this paper
• Peptidomics and traumatic brain injury: biomarker utilities for a theragnostic approach

  2020cites this paper
• Частота полиморфизма генов цитокинов у доношенных новорождённых детей с гипоксическими событиями

  2020cites this paper
• Urinary Nerve Growth Factor in full-term, preterm and intra uterine growth restriction neonates: Association with brain growth at 30-40 days of postnatal period and with neuro-development outcome at two years. A pilot study.

  2020cites this paper
• Attenuation of the mutual elevation of iron accumulation and oxidative stress may contribute to the neuroprotective and anti-seizure effects of xenon in neonatal hypoxia-induced seizures.

  2020cites this paper
• Blood Biomarkers and 6- to 7-Year Childhood Outcomes Following Neonatal Encephalopathy

  2020cites this paper
• Inhibiting ER Stress Weakens Neuronal Pyroptosis in a Mouse Acute Hemorrhagic Stroke Model

  2020cites this paper
• Lessons learned from proteome analysis of perinatal neurovascular pathologies

  2020cites this paper
• Interferon-gamma facilitates neurogenesis by activating Wnt/β-catenin cell signaling pathway via promotion of STAT1 regulation of the β-catenin promoter.

  2020cites this paper
• Type 2 Innate Lymphoid Cells Accumulate in the Brain After Hypoxia-Ischemia but Do Not Contribute to the Development of Preterm Brain Injury

  2020cites this paper
• Plasma and CSF Candidate Biomarkers of Neonatal Encephalopathy Severity and Neurodevelopmental Outcomes.

  2020cites this paper
• Aberrant expression of miR-199a in newborns with hypoxic-ischemic encephalopathy and its diagnostic and prognostic significance when combined with S100B and NSE

  2020cites this paper